Antegenes
PrivateLast Round
Grant
Aug 2, 2022
Total Funding Raised
$2.91M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Antegenes is a health technology company that develops and provides polygenic risk score-based genetic tests for the personalized prevention and early detection of common cancers.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antegenes Comparables
Compare Antegenes with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GENinCode PLC | 81% | |
| Allelica, Inc. | 80% | |
| Genetic Technologies Limited | 76% | |
Antegenes Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 2, 2022 | ||||
| Grant | Aug 2, 2022 | ||||
| Seed | Aug 2, 2022 | ||||
| Seed | Nov 9, 2021 |
Key People
Founding team and executive leadership
Antegenes Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EIT Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 45% MoM, reaching 1.1K.
- May 19, 2026
Monthly visitors increased 53% MoM.
Antegenes Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Antegenes's valuation, stock price, and market status.